SCHEMBL4648550

SCHEMBL4648550

Cc1ccc(-c2cccc(S(=O)(=O)O)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
TSHR P16473 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
HSD17B10 Q99714 1/20 0.48
MAOA P21397 3/20 0.48
MAOB P27338 3/20 0.48
LOXL2 Q9Y4K0 2/20 0.47
LOX P28300 1/20 0.47
SNCA P37840 1/20 0.46
C1S P09871 1/20 0.46
MCL1 Q07820 2/20 0.46
CA2 P00918 2/20 0.44
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
PTPN5 P54829 1/20 0.44
SYK P43405 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HSD17B1 P14061 2/20 0.43
HSD17B2 P37059 2/20 0.43
DHODH Q02127 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27903792 0.88 TSHR (0.59) ALDH1A1TSHRTDP1HSD17B10CA2
SCHEMBL10655412 0.86 TSHR (0.54) ALDH1A1TSHRTDP1HSD17B10CA2
SCHEMBL975190 0.86 TSHR (0.61) ALDH1A1TSHRTDP1HSD17B10SNCA
SCHEMBL307044 0.84 TSHR (0.62) ALDH1A1TSHRTDP1HSD17B10LOX
SCHEMBL1416443 0.84 TSHR (0.59) ALDH1A1TSHRTDP1HSD17B10SNCA
SCHEMBL5081851 0.84 TSHR (0.59) ALDH1A1TSHRTDP1HSD17B10SNCA
SCHEMBL15509798 0.84 TSHR (0.59) ALDH1A1TSHRTDP1HSD17B10SNCA
SCHEMBL15771709 0.84 PTGS2 (0.50) ALDH1A1TSHRTDP1HSD17B10CA2
SCHEMBL14580865 0.82 SNCA (0.46) ALDH1A1TDP1MAOAMAOBLOXL2
Water SCHEMBL15608810 0.82 TSHR (0.60) ALDH1A1TSHRTDP1HSD17B10LOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US claimed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO claimed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP claimed
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US disclosed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO disclosed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP disclosed
US-3985797-A Hydroxylation of aromatic compounds UOP INC. (US) 1976-10-12 US disclosed
US-3985796-A Hydroxylation of aromatic compounds UOP INC. (US) 1976-10-12 US disclosed
US-3931295-A Hydroxylation of aromatic compounds UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255117-A1 SULFONYLTRYPTOPHANOLS FSHR, NPY1R, GNRHR ALDH1A1 4169/4885TSHR 50/4885TDP1 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.